Carl-Olof Bouveng

Partner

Contact
carl-olof.bouveng@cirio.se +46 76 617 08 90
Carl-Olof Bouveng

Carl-Olof has key expertise in corporate law, mergers & acquisitions and insurance. Carl-Olof represents publicly and privately held companies as well as private equity sponsors in a broad range of corporate transactions, including mergers and acquisitions, reorganizations and tender offers. He also advises on capital market, corporate governance and general corporate matters, as well as regulatory issues in the insurance industry. Carl-Olof also represents a number of international NGOs.

Carl-Olof has extensive experience in all aspects of corporate/M&A and is a recent Chair of the International Section of the New York State Bar Association. He is also admitted to practice in New York.

Expertise
Synergy areas
  • Experience

    Advised:

    • AstraZeneca in the sale of US rights to Synagis to Swedish Orphan Biovitrum AB (publ) (Sobi) against an upfront consideration of $1.5bn,

    • Axel Johnson International in acquisitions in the Baltics and New Zealand,

    • Autobahn Tank & Rast in acquisition of Wayne’s Coffee,

    • Reorganizations and acquisitions by Hewlett-Packard,

    • Acquisitions by Facebook and Cisco Systems,

    • Beijing Water’s acquisition of Purac,

    • Norvestor Equity’s sale of the retail chain Life.

  • Rankings

    Carl-Olof is named as a leading lawyer in Sweden in Corporate/M&A by Chambers and Partners.

  • CV
    2019-
    Cirio
    1997-2018
    Lindahl law firm, Partner
    2010-2011
    New York State Bar Association
    1990-1997
    Mannheimer Swartling Advokatbyrå
    1989-1990
    Covington & Burling in Washington D.C.
    Languages:

    Swedish and English

  • Education
    1988
    LL.M.
  • Membership
    1995
    Member of the Swedish Bar Association
    1991
    Admitted to New York Bar
Expertise
Synergy areas